GlassScriptPhysician profile
Christine Arney Green
NPI 1972658458
$244.93
in general payments reported to CMS, 2019-2025
7 companies · $42.89 in 2025
The $42.89 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.13 · 2021: $11.34 · 2022: $48.32 · 2023: $40.94 · 2024: $85.31 · 2025: $42.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $169.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $59.27 | 2024 | Xt Cdx |
| Siemens Medical Solutions USA, INC. | $44.26 | 2020-2023 | Atellica Ch 930 Analyzer, Atellica Im 1300 Analyzer |
| Medline Industries LP | $42.89 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.04 | 2024 | Tagrisso |
| Merck Sharp & Dohme LLC | $24.56 | 2022 | |
| Radiometer America, INC | $24.15 | 2023 | |
| Roche Diagnostics Corporation | $23.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.